BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10225537)

  • 1. 5-methoxyindole metabolites of L-tryptophan: control of COX-2 expression, inflammation and tumorigenesis.
    Wu KK; Cheng HH; Chang TC
    J Biomed Sci; 2014 Mar; 21(1):17. PubMed ID: 24589238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly pathogenic porcine reproductive and respiratory syndrome virus induces prostaglandin E2 production through cyclooxygenase 1, which is dependent on the ERK1/2-p-C/EBP-β pathway.
    Bi Y; Guo XK; Zhao H; Gao L; Wang L; Tang J; Feng WH
    J Virol; 2014 Mar; 88(5):2810-20. PubMed ID: 24352469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celecoxib extends C. elegans lifespan via inhibition of insulin-like signaling but not cyclooxygenase-2 activity.
    Ching TT; Chiang WC; Chen CS; Hsu AL
    Aging Cell; 2011 Jun; 10(3):506-19. PubMed ID: 21348927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpinia galanga extracts downregulate interleukin-1β-induced matrix metalloproteinases expression in human synovial fibroblasts.
    Pothacharoen P; Choocheep K; Phitak T; Pompimon W; Kongtawelert P
    In Vitro Cell Dev Biol Anim; 2011 Mar; 47(3):183-7. PubMed ID: 21132464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-nitroso human serum albumin given after LPS challenge reduces acute lung injury and prolongs survival in a rat model of endotoxemia.
    Jakubowski A; Maksimovich N; Olszanecki R; Gebska A; Gasser H; Podesser BK; Hallström S; Chlopicki S
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Mar; 379(3):281-90. PubMed ID: 18854985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celecoxib as an in vivo probe of cyclooxygenase-2 mechanisms underlying retrograde amnesia in an animal model of ECT.
    Andrade C; Thyagarajan S; Singh NM; Vinod PS; Sanjay Kumar Rao N; Chandra JS
    J Neural Transm (Vienna); 2008 Jul; 115(7):1063-70. PubMed ID: 18523723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. n-3, n-6, and n-9 polyunsaturated fatty acids--which composition in parenteral nutrition decreases severity of acute hemorrhagic necrotizing pancreatitis in rats?
    Kilian M; Heukamp I; Gregor JI; Bretthauer C; Walz MK; Jacobi CA; Lochs H; Schimke I; Guski H; Wenger FA
    Int J Colorectal Dis; 2006 Jan; 21(1):57-63. PubMed ID: 15864609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lornoxicam on the physiology of severe sepsis.
    Memiş D; Karamanlioğlu B; Turan A; Koyuncu O; Pamukçu Z
    Crit Care; 2004 Dec; 8(6):R474-82. PubMed ID: 15566594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis.
    Hedner T; Samulesson O; Währborg P; Wadenvik H; Ung KA; Ekbom A
    Drugs; 2004; 64(20):2315-43; discussion 2344-5. PubMed ID: 15456329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does cyclooxygenase-2 affect blood pressure?
    Cheng HF; Harris RC
    Curr Hypertens Rep; 2003 Feb; 5(1):87-92. PubMed ID: 12530941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological functions of cyclooxygenase 2: control of its expression and activity].
    Jacquemin C
    J Soc Biol; 2000; 194(3-4):189-93. PubMed ID: 11324321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COX-1 and COX-2 in health and disease.
    Adelizzi RA
    J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S7-12. PubMed ID: 10643175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase 2: from inflammation to carcinogenesis.
    Ristimäki A
    Novartis Found Symp; 2004; 256():215-21; discussion 221-6, 259-69. PubMed ID: 15027493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
    Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
    J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific COX-2 inhibitors in arthritis, oncology, and beyond: where is the science headed?
    Lipsky PE
    J Rheumatol Suppl; 1999 Apr; 56():25-30. PubMed ID: 10225537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
    Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
    In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.